Since trials investigating the potential use of anti-BRAF agents in the management of gliomas are ongoing, it cannot be excluded, in case of successful results, that the testing of BRAF status in ...
In other words, the presence of BRAF in your blood test could indicate the presence or progression of lung cancer. The BRAF mutation is a rare mutation. It is only reported in about 3% to 5% of ...
with a BRAF V600E mutation, confirmed by an FDA-approved test. This decision follows a significant improvement in response rate and durability response observed in the treatment-naïve subjects in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback